Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07203183Not Yet Recruiting

Dengue - Sample Collection Study Pakistan

Role: collaborator

NCT07163143Phase 3Not Yet Recruiting

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Role: collaborator

NCT06606301Completed

Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma

Role: collaborator

NCT04551209Not ApplicableCompleted

"Effect of Apical Patency on Post-endodontic Pain"

Role: lead

All 4 trials loaded